12:00 AM
 | 
Feb 16, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Chiron regulatory update

The FDA granted marketing approval for CHIR's RIBA HCV 3.0 Strip Immunoblot Assay to detect...

Read the full 53 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >